Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper publication for Unaudited Standalone and Consolidated financial results for quarter and half year ended September 30, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted to the exchange a copy of the newspaper advertisement carrying its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. This is a routine regulatory filing required by SEBI, where listed companies must publish their quarterly results in newspapers. The detailed financial numbers would have been filed separately with the exchange earlier. No new business or financial information is disclosed in this particular filing beyond what was already reported.
This is a standard compliance submission with no direct impact on shareholders or stock price. Investors should refer to the originally filed Q2/H1 FY26 results for actual financial performance and outlook.